STOCKHOLM Jan 25 Swedish medical technology
group Getinge posted core fourth-quarter profits on
Friday that were roughly unchanged from the year before and said
the profit outlook for 2013 was favourable.
"Demand in the markets outside North America and Western
Europe, which comprise an increasing share of group sales, is
expected to continue to show strong growth in terms of
medical-technical capital goods such as disposables and
services," it said.
Operating profit before interest, amortisation and
restructuring costs edged up 1 percent from a year earlier to
1.94 billion crowns ($298.6 million), compared with a consensus
forecast in a Reuters poll of analysts for 1.93 billion.
Getinge on Jan. 11 warned of a 2012 profit short of
expectations after falling demand in the last quarter in Europe
hit invoicing and orders. It said full-year pretax profit was
some 3.6 billion crowns before acquisition and restructuring
costs of 170 million related to the U.S.-based Therapeutic
Support Systems, which it bought last year.
($1 = 6.4966 Swedish crowns)
(Reporting by Anna Ringstrom)